Shining light on novel targets and therapies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2016.203.pdf
Reference10 articles.
1. Denny, S. K. et al. Nfib promotes metastasis through a widespread increase in chromatin accessibility. Cell 166, 328–342 (2016).
2. Semenova, E. A. et al. Transcription factor NFIB is a driver of small cell lung cancer progression in mice and marks metastatic disease in patients. Cell Rep. 16, 631–643 (2016).
3. Wu, N. et al. NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer. Oncotarget http://dx.doi.org/10.18632/oncotarget.11583 (2016).
4. Rudin, C. M. et al. Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, open-label, phase I study. Lancet Oncol. http://dx.doi.org/10.1016/S1470-2045(16)30565-4 (2016).
5. Antonia, S. J. et al. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial. Lancet Oncol. 17, 883–895 (2016).
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of thoracic radiotherapy on first‐line treatment outcomes in ES‐SCLC patients;Cancer Medicine;2024-09
2. Small Cell Lung Cancer—An Update on Chemotherapy Resistance;Current Treatment Options in Oncology;2024-07-27
3. Mechanistic insights on the role of competing endogenous RNA regulatory networks (ceRNETs) in small cell lung cancer;Advances in Cancer Biology - Metastasis;2024-07
4. Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions;CA: A Cancer Journal for Clinicians;2023-06-17
5. A model-based head-to-head comparison of single-agent lurbinectedin in the pivotal ATLANTIS Study;Frontiers in Oncology;2023-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3